Pharmstandard

Pharmstandard

Pharmstandard

Follow us
Alexa global traffic share
Latest investments Show all
$8,500,000
Venture capital (Series B)
TearSolutions
$20,000,000
Venture capital (Series C)
Avelas Biosciences
Team Size
1–10
Employees
Location
Headquarters
Markets focus
Past year's investments

Pharmstandard participated in fewer than 3 rounds over the past year

Latest rounds
  • TearSolutions: Venture capital (Series B) ($8.5M)
  • Avelas Biosciences: Venture capital (Series C) ($20M)
  • Jounce Therapeutics: Venture capital (Series B) ($56M)